Results 111 to 120 of about 15,945 (274)
Barrett′s esophagus: Where do we stand?
Barrett′s esophagus (BE) is a precursor for esophageal adenocarcinoma, which has an increased incidence rate over the last few decades. Its importance stems from the poor five-year survival of esophageal adenocarcinoma and current data that ...
Al Madi Majid
doaj
(1) Background: Barrett’s esophagus (BE) is a complication of chronic gastroesophageal reflux disease and is a precursor to esophageal adenocarcinoma.
Zhao Wang +7 more
doaj +1 more source
Immunohistochemical biomarkers for risk stratification of neoplastic progression in Barrett esophagus [PDF]
Vincent T. Janmaat +5 more
openalex +1 more source
Mixed Neuroendocrine – Nonneuroendocrine Neoplasm Arising in Barrett\'s Esophagus
Soon Liang Lee +4 more
openalex +1 more source
ABSTRACT The ongoing invasion of the zoonotic parasite Angiostrongylus cantonensis threatens humans, other mammals, and birds. In Mallorca, neurological disorders associated with this parasite are increasingly reported in free‐living Algerian hedgehogs, Atelerix algirus, raising public health concerns.
Anna Šipková +7 more
wiley +1 more source
ABSTRACT Background Observational studies have indicated that gastroesophageal reflux disease (GERD) is connected to myocardial infarction (MI). Nonetheless, the question of causality in these relationships remains unresolved, given the potential influence of confounding variables.
Xiaoya Zheng +5 more
wiley +1 more source
The novel manometric parameter Milan Score could be useful in predicting which patients with type 2 EGJ have a high likelihood of objective GERD, therefore discriminating which patients may need escalation of GERD investigation and management. ABSTRACT Introduction High‐resolution manometry (HRM) allows assessment of esophagogastric junction (EGJ ...
Davide Ferrari +29 more
wiley +1 more source
Management of Barrett esophagus: a practical guide for clinicians based on the BADCAT and BoB CAT recommendations [PDF]
Jakob A Jankowski +2 more
openalex +1 more source
This phase 2 proof‐of‐concept trial evaluated the efficacy and safety of velusetrag in patients with chronic intestinal pseudo‐obstruction. Velusetrag treatment was generally well tolerated and was associated with improved symptoms and a reduction in pseudo‐obstructive episodes versus placebo, although these differences did not reach statistical ...
Carolina Malagelada +9 more
wiley +1 more source
Real-world upper endoscopy utilization patterns among patients with gastroesophageal reflux disease, Barrett esophagus, and Barrett esophagus-related esophageal neoplasia in the United States. [PDF]
Sharma P +8 more
europepmc +1 more source

